Capital Group Private Client Services Inc. acquired a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 6,354 shares of the biopharmaceutical company’s stock, valued at approximately $1,207,000. A number of other […]
HC Wainwright reissued their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a report published on Wednesday, Benzinga reports. The brokerage currently has a $395.00 price objective on the biopharmaceutical company’s stock. Other equities analysts also recently issued reports about the company. Sanford C. Bernstein dropped their price target on Alnylam […]
FY2023 EPS Estimates for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Raised by Analyst themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Mackenzie Financial Corp boosted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 16.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,096 shares of the biopharmaceutical company’s stock after purchasing an additional 4,299 shares […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price reduced by Citigroup from $266.00 to $233.00 in a research note released on Tuesday morning, MarketBeat.com reports. They currently have a buy rating on the biopharmaceutical company’s stock. Several other research firms have also issued reports on ALNY. Royal Bank of Canada restated an outperform […]